Ryan Franklin’s career was interrupted by one of Major League Baseball’s earliest positive steroid suspensions under the league’s increasingly aggressive drug-testing program. On August 2, 2005, Franklin became only the eighth MLB player—and the second Seattle Mariner—to test positive for steroid use. MLB imposed a 10-day suspension, a punishment that was relatively short by later standards but carried considerable reputational weight because the league was still struggling to establish credibility after years of accusations that performance-enhancing drugs had distorted baseball’s record book. The positive came after Franklin had endured difficult seasons in Seattle, including a 4–16 record in 2004 and a 5.10 ERA in 2005, making the case part of the wider debate over whether struggling or marginal players were also turning to banned substances rather than merely chasing historic power numbers.
Franklin’s doping controversy resurfaced two years later when his name appeared in Senator George Mitchell’s 2007 investigation into steroid and human-growth-hormone use in baseball. The Mitchell Report transformed individual suspensions into a broader institutional scandal, portraying performance-enhancing drugs as a problem involving players, trainers, clubhouse personnel, and the league’s previously inadequate enforcement culture. Franklin ultimately continued his career, later becoming an All-Star closer with the St. Louis Cardinals in 2009, but the suspension and report permanently attached his name to baseball’s drug era. He retired in 2011 after a sharp late-career decline, leaving the steroid episode as the defining controversy surrounding an otherwise lengthy MLB career.
Follow the sources
Status and citations are supplied by the archive. AI concept art is an interpretation, not historical evidence.
AI concept artwork · not archival photography